Cerebras Q3 Test: $25.4 Billion Backlog Meets Margin Risk

By Rebecca Stone

Cerebras enters Thursday’s Q3 2026 report with $25.4 billion in remaining performance obligations, most of them tied to OpenAI, according to Investing.com, while its shares traded at $97.84 in U.S. premarket trading on Nov. 12. The immediate issue is whether core revenue can reach or exceed the company’s $214 million to $216 million guide and whether margins follow management’s stated path after Q3.

At 8:09 a.m. ET, Yahoo Finance quoted CBRS at $97.84, down 3.2% from Wednesday’s $101.08 close. Options implied a roughly 12% to 14% move after the print, with reference levels of $111 above and $84 below. Regular trading opens at 14:30 GMT; results follow after the U.S. close, with the call starting at 5 p.m. ET, or 22:00 GMT.

What will Cerebras report?

The company’s August guide called for Q3 core revenue of $214 million to $216 million, core gross margin of 38% to 40%, and core operating margin of negative 25% to negative 23%. Consensus sits at or just above that range: GuruFocus and Benzinga use about $214.7 million, Zacks $215.82 million, and TipRanks $217.7 million.

Zacks expects a 13-cent loss per share, GuruFocus about 14 cents and TipRanks 15 cents; TipRanks also cites a 10-cent loss in the year-earlier period. Cerebras generated $209.9 million in Q2 core revenue, up 103% year over year, at a 40.6% core gross margin, Investing.com reported.

Management called Q3 the “low point” for margins because some capacity is rented back from partners while Cerebras-owned systems are built. That leaves revenue and profitability on different timelines. For 2026, Cerebras guides to $880 million to $890 million in core revenue; management has said core revenue should more than triple in 2027.

What moved the stock into the print?

CBRS gained about 8% Wednesday, rising from $93.66, as CoreWeave’s raised guidance lifted chip and AI infrastructure stocks. TipRanks also linked the move to a new Cerebras customer deal with Bilt. The gain did not survive premarket trading, as a Wall Street Journal report that Nvidia’s board was preparing to remove chief executive Jensen Huang weighed on AI stocks. Nvidia shares fell sharply before the open, but no decision had been announced.

Cerebras listed on Nasdaq on May 14 at $185 per share, leaving the Nov. 12 premarket price about 47% below its IPO price. Its 52-week range is $77.84 to $386.34, and the low came Nov. 5 before shares recovered above $100 by Wednesday’s close. Separately, the 180-day IPO lock-up ended Nov. 10, according to TipRanks, allowing early holders to sell.

How much of the backlog can convert?

The $25.4 billion figure represents remaining performance obligations, not recognized Q3 revenue, and most of it is tied to OpenAI. The source does not provide an exact OpenAI percentage. Investors will look for evidence that those obligations convert into shipments and sales, alongside AWS Bedrock availability expected in Q1 2027.

The timing matters because the bear case depends on a good top line failing to repair margins or the full-year outlook. Morgan Stanley’s Joseph Moore also cited short-term data-center capacity constraints and possible margin pressure when he reduced his price target.

What do analysts expect?

All nine analysts tracked by TipRanks rate CBRS a Buy, with an average target of $267.13, although most have reduced targets recently. The targets describe how those analysts see the business in 2027; they do not forecast the immediate reaction to Thursday’s print.

• Morgan Stanley’s Joseph Moore cut his target to $178 from $279, citing short-term data-center capacity constraints and possible margin pressure.
• UBS’s Timothy Arcuri cut his target to $250 from $330.
• Wedbush’s Matt Bryson cut his target to $190 from $290 and retained an Outperform rating. He expects a modest revenue beat and higher guidance, helped by OpenAI commitments and inference demand.

Which outcomes frame the stock?

TipRanks’ options data implied a 13.7% move in either direction, while GuruFocus estimated about 12% and put implied volatility above 100%. Neither provider disclosed the expiry used, so the market signal is a range rather than a precise forecast. A 13% move from $97.84 computes to roughly $111 or $85; the source’s round reference levels are $111 and $84.

The stock fell after both earlier public-company reports: 19.6% after Q1 and 11.85% after Q2, according to TipRanks. Other data providers gave different Q2 figures, but both post-report reactions were negative.

• Bear, $84: Revenue lands near guidance, but margins or the full-year outlook disappoint. That sits about 14% below the premarket price, with the $77.84 52-week low below it.
• Base, $92 to $102: Results match guidance and the full-year outlook does not change. The range brackets Wednesday’s $101.08 close and Tuesday’s $93.66 close.
• Bull, $111: Revenue exceeds $217.7 million, the full-year guide rises, and OpenAI and AWS demand begins converting into sales. That would put shares about 13.5% above the premarket quote.

These are reference levels, not forecasts.

What changes the picture after the print?

• Core gross margin lands inside or above the 38% to 40% guide, followed by a clear path to recovery in Q4 as Cerebras-owned systems come online.
• Cerebras raises or cuts its $880 million to $890 million full-year core revenue guide.
• Management discloses more detail on OpenAI concentration within the $25.4 billion obligations and the timing of AWS Bedrock availability in Q1 2027.
• Reported GAAP results and adjusted core figures separate cleanly; source providers published conflicting Q2 numbers, so headline comparisons may differ.
• Nvidia makes a board decision on Huang before or after the report, or adds context through its own Nov. 17 results.

The immediate catalyst is revenue near $215 million, but the durable test is conversion. If the OpenAI-backed backlog reaches customers, owned systems lift margins and the 2027 growth plan gains credibility, the shares have a path toward the $111 bull case; if not, the $84 reference and $77.84 low remain relevant.